| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/16/2011 | CN101977603A Methods using immunomodulatory compounds for modulating level of cd59 |
| 02/16/2011 | CN101974535A Preparation and application of novel anti-ErbB2 humanized antibody MIL12 |
| 02/16/2011 | CN101974489A A H1N1 influenza virus and application thereof |
| 02/16/2011 | CN101974472A Marker-free gene deletion attenuated mutant strain of Edwardsiella tarda wild strain as well as relevant preparations and application thereof |
| 02/16/2011 | CN101974086A Preparation method and applications of anti-latent membrane protein LMP2A monoclonal antibody |
| 02/16/2011 | CN101974072A Escherichia coli TolC antigen as well as antibody and application thereof |
| 02/16/2011 | CN101974071A Insulin B chain HLA-A*0201 restrictive CTL epitope modified peptide ligand and acquisition method and application thereof |
| 02/16/2011 | CN101972479A Preparation process of intravenous injection human immunoglobulin |
| 02/16/2011 | CN101972478A 抗体治疗 Antibody therapy |
| 02/16/2011 | CN101972477A Zinc phosphate vaccine adjuvant |
| 02/16/2011 | CN101972476A DNA vaccine adjuvant using Micro RNA-155 and construction method thereof |
| 02/16/2011 | CN101972475A Bacterial polysaccharide-protein conjugate vaccine and preparation method thereof |
| 02/16/2011 | CN101972474A Freeze dried herpes zoster attenuated live vaccine and preparation method |
| 02/16/2011 | CN101972473A Preparation method of live vaccine for gosling plague and live vaccine prepared therefrom |
| 02/16/2011 | CN101972472A Method for purifying and preparing allergen vaccine |
| 02/16/2011 | CN101509002B Recombinant rubella virus protein and uses thereof |
| 02/16/2011 | CN101343323B Anti-interleukins-8 antibody |
| 02/16/2011 | CN101249262B Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof |
| 02/15/2011 | US7888491 Kits containing reagents for diagnosing human and canine ehrlichiosis; immunogens containing one or more OMP proteins or P30F proteins |
| 02/15/2011 | US7888490 Site-directed mutagenesis of the native genes of the toxin proteins, Protective Antigen, Lethal Factor and Edema Factor, using polymerase chain reaction; expression and purification |
| 02/15/2011 | US7888485 Anti-pleiotrophin antibodies and methods of use thereof |
| 02/15/2011 | US7888484 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) |
| 02/15/2011 | US7888483 Antagonists of protease activated receptor-1 (PAR1) |
| 02/15/2011 | US7888482 Antibodies that bind PAR-2 |
| 02/15/2011 | US7888481 Anti-interferon alpha monoclonal antibodies and methods for use |
| 02/15/2011 | US7888479 Humanized antibodies against monocyte chemotactric proteins |
| 02/15/2011 | US7888477 Isolated polynucleotide of ovarian tumor polypeptides, immunogenic portions, polynucleotides that encode polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 02/15/2011 | US7888473 Non-functional P2X7 receptor |
| 02/15/2011 | US7888472 Optimized multi-epitope constructs and uses thereof |
| 02/15/2011 | US7888469 Post-translation modification and clostridial neurotoxins |
| 02/15/2011 | US7888461 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching |
| 02/15/2011 | US7888460 a mutant gliadin protein with the mutation in the epitope 62PQPQLPY68, or a fragment of such mutant protein (non-glidin sequence), decreases the ability of the epitope to induce a Tcell or antibody response |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888326 Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5 |
| 02/15/2011 | US7888135 Diagnostic assay for Trypanosoma cruzi infection |
| 02/15/2011 | US7888115 Major histocompatibility complex amino acid sequences for use as tool in developing antibodies and vaccine for use in prevention and treatment of cell proliferative disorders; immunotherapy |
| 02/15/2011 | US7888112 Isolated polynucleotides comprising a nucleic acid which operably encodes 50 contiguous amino acids, nucleic acids are fragments of a codon-optimized coding region; a carrier |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888052 detecting a Cripto polypeptide; for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 02/15/2011 | US7888039 uses the heat shock protein 60 (Hsp60) of Spiroplasma mirum; rapid detection, noninvasive ; Spiroplasma infection |
| 02/15/2011 | US7888037 Diagnostic kit for detecting pulmonary and extra pulmonary tuberculosis |
| 02/15/2011 | US7888004 HCV non-structural polypeptide |
| 02/15/2011 | US7888003 Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887822 Peptides for stimulating an immune response against melanoma |
| 02/15/2011 | US7887821 from birch trees, weeds, herbs and grass via contacting with liquid extraction agent, separating liquids and solids, removing low molecular fractions via ultrafiltration, diafiltration, and/or dialysis |
| 02/15/2011 | US7887820 drug screening; chronic rhinosinusitis |
| 02/15/2011 | US7887819 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
| 02/15/2011 | US7887818 Neospora caninum vaccine |
| 02/15/2011 | US7887817 Process for preventing protozoal diseases |
| 02/15/2011 | US7887816 Attenuated microorganisms for the treatment of infection |
| 02/15/2011 | US7887815 Peptide diagnostic agent for lyme disease |
| 02/15/2011 | US7887814 binding proteins, fused with transferrins; for treatment of Alzheimer's, Down Syndrome, infant encephalitis, AIDS, and autoimmune diseases |
| 02/15/2011 | US7887813 Such as adefovir dipivoxil, lamivudine, tenofovir, and (-)- beta -L-2'-3'-dideoxy-5-fluoro-3'-thiacydidine; vaccines |
| 02/15/2011 | US7887812 Live attenuated Leishmania vaccines |
| 02/15/2011 | US7887811 Vaccine antibodies; chelate solution of TNF alpha with EDTA; add diphtheria toxoid carrier protein; add glutaraldehyde; glycine blocking reagent; dialysis, ultrafiltration, Tangential Flow Filtration; immunoadjuvants |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887809 Neovascular-targeted immunoconjugates |
| 02/15/2011 | US7887808 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887805 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887803 antibody, or binding fragment thereof, that binds selectively to an epitope presented by misfolded form of superoxide dismutase 1; use in diagnosis, prognosis and therapeutic intervention in neurodegenerative Alzheimer's disease, Parkinson's disease, Huntington's disease |
| 02/15/2011 | US7887802 immunohistochemistry; skin thickening caused by ultraviolet treated by using the antibody; inhibit production of IFN-.gamma; promoting keratinocyte differentiation induction and suppressing epidermal thickening, skin cancer; inhibiting growth of keratinocytes; promotes hair growth; hyperplasia |
| 02/15/2011 | US7887801 encoding the scFv(FRP5) antibody fragment; prevents the generation of the undesired by-product in the context of an scFv(FRP5)-ETA fusion protein; derived from the ErbB2-specific antibody FRP5; cancer, Pseudomonas exotoxin |
| 02/15/2011 | US7887800 activating endothelial growth factors VEGF-C or vascular endothelial growth factor D (VEGF-D) with plasmin; Angiogenesis |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887798 Methods of treating cancer by administering antibodies to CD200 |
| 02/15/2011 | US7887797 Immunoglobulin fractions |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | CA2508757C Coccidial vaccine and methods of making and using same |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2354046C New cancer treatments |
| 02/15/2011 | CA2352765C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/15/2011 | CA2347084C Hepatitis a vaccines |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2286397C Humanized antibodies and methods for forming humanized antibodies |
| 02/15/2011 | CA2200691C Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 02/15/2011 | CA2196304C Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/15/2011 | CA2074370C Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 02/11/2011 | CA2721040A1 Procyanidin extracts of cinnamon, litchi and arachis useful in the treatment of retroviral infections |
| 02/10/2011 | WO2011017680A1 Computer methods and devices for detecting kidney damage |
| 02/10/2011 | WO2011017442A2 Anti-rsv immunogens and methods of immunization |
| 02/10/2011 | WO2011017162A2 Methods for enhancing antigen-specific immune responses |
| 02/10/2011 | WO2011016830A1 Herpes virus backbone for viral vaccine and vaccine based thereon |
| 02/10/2011 | WO2011016568A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016567A1 Humanized anti-amyloid-β oligomer antibody |
| 02/10/2011 | WO2011016461A1 Tumor angiogenesis inhibitor |
| 02/10/2011 | WO2011016239A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011016238A1 Antibodies that specifically bind to a beta oligomers and use thereof |
| 02/10/2011 | WO2011015656A2 Composition for treating hbv infection |
| 02/10/2011 | WO2011015614A1 A vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine |
| 02/10/2011 | WO2011015591A1 Immunogenic composition comprising antigenic s. aureus proteins |
| 02/10/2011 | WO2011015590A1 Immunogenic composition comprising variants of staphylococcal clumping factor a |
| 02/10/2011 | WO2011015121A1 Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |
| 02/10/2011 | WO2011014947A1 Porphyromonas gingivalis polypeptides |